Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 31 October 2006
Vol. 2006, Issue 359, p. tw374
[DOI: 10.1126/stke.3592006tw374]

EDITORS' CHOICE

Neuroscience Alzheimer’s Enzyme and Myelination

Stella M. Hurtley

Science, AAAS, Cambridge CB2 1LQ, UK

beta-secretase activity is crucial in the production of pathological beta-amyloid in Alzheimer's disease (AD). However, its role in normal physiology is unclear, especially given the absence of an obvious phenotype in a knockout mouse for BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1). Willem et al. found that BACE1 (but not its close homolog BACE2) is required for neuregulin (NRG)-mediated peripheral nerve myelination. NRG1 was an in vivo substrate of BACE1, and the BACE-1 knockout mouse fully phenocopied hypomyelination observed in NRG1 heterozygous mutant mice. Thus, BACE-1 plays a physiological role during development in myelination.

M. Willem, A. N. Garratt, B. Novak, M. Citron, S. Kaufmann, A. Rittger, B. DeStrooper, P. Saftig, C. Birchmeier, C. Haass, Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314, 664-666 (2006). [Abstract] [Full Text]

C. Glabe, Avoiding collateral damage in Alzheimer’s disease treatment. Science 314, 602-603 (2006). [Abstract] [Full Text]

Citation: S. M. Hurtley, Alzheimer’s Enzyme and Myelination. Sci. STKE 2006, tw374 (2006).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882